---

LIVECMECommunicationEthics/ProfessionalismPSRM - Patient Safety/Risk ManagementComplimentary - No FeeState Required CME

Friday, December 11, 2020, 4:00 PM - 5:00 PM EST, Online, Philadelphia, PA

Caring for children during the COVID-19 pandemic has raised a number of ethical challenges. When children suffer from COVID-19, or the multi-system inflammatory response sometimes associated with it, how should unapproved therapies be used and what sort of oversight is appropriate for innovative approaches outside the research context? How can the impact of the pandemic best be mitigated for pediatric patients suffering from other diseases and conditions, including considerations related to hospital visitation policies and delays in care? Finally, as we consider promising COVID-19 vaccines, how should we go about ethically including children in vaccine research?  

1. Assess the issues raised by the use of unapproved therapies in treating children with COVID-19
2. Consider how the impact of the COVID-19 pandemic can be mitigated for pediatric patients suffering from other diseases and conditions
3. Identify ethical challenges associated with pediatric inclusion in and exclusion from COVID-19 vaccine trials

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Penn Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours)